Implementation Assessment Management Measures for the 2026 Restricted Stock Incentive Plan
Hangzhou Baicheng Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "the Company") aims to further improve its corporate governance structure, establish a long-term incentive and constraint mechanism, attract and retain core management, technical, and business talents, fully mobilize their enthusiasm and creativity, effectively enhance the cohesion of the core team and the company's core competitiveness, and align the interests of shareholders, the company, and the core team. This is to ensure that all parties focus on the long-term development of the company and achieve the company's development strategy and operational objectives while fully safeguarding shareholder interests. Based on the principle of equity between returns and contributions, the Company has formulated the "Draft of the 2026 Restricted Stock Incentive Plan of Hangzhou Baicheng Pharmaceutical Technology Co., Ltd." (hereinafter referred to as "this Restricted Stock Incentive Plan" or "this Incentive Plan"). To ensure the smooth implementation of this Restricted Stock Incentive Plan, this document is formulated in accordance with relevant laws, administrative regulations, normative documents, and the provisions of the Articles of Association of Hangzhou Baicheng Pharmaceutical Technology Co., Ltd., combined with the actual situation of the Company.
Article 1 Purpose of Assessment
The purpose of this document is to strengthen the planning of the execution of the Company's Restricted Stock Incentive Plan, quantify the specific goals set by the plan, promote the scientific, standardized, and institutionalized management of the assessment of incentive objects, and ensure the achievement of various performance indicators of the Restricted Stock Incentive Plan. At the same time, it aims to guide the incentive objects to improve work performance, enhance work capabilities, and objectively and fairly evaluate employees' performance and contributions, providing an objective and comprehensive basis for the execution of this incentive plan.
Article 2 Principles of Assessment
- Adhere to the principles of fairness, justice, and openness, and strictly assess and evaluate the incentive objects according to this document.
- The assessment indicators should be combined with the company's medium- and long-term development strategy and annual operational objectives, as well as the work performance, work capabilities, and work attitudes of the incentive objects.
Article 3 Scope of Assessment
This document applies to all incentive objects determined by this incentive plan, including directors, senior management personnel, and core technical/business personnel employed by the Company (including subsidiaries), excluding independent directors of Baicheng Pharmaceutical. Among the above incentive objects, the Company's directors and senior management must be elected by the shareholders' meeting or appointed by the board of directors. All incentive objects must sign labor contracts or employment contracts with the Company or its controlling subsidiaries during the assessment period of this incentive plan.